Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-06

FDA Approved: CEVIMELINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approves Advagen Pharma Ltd's cevimeline hydrochloride as an original application. It is indicated for the treatment of xerostomia in Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cevimeline hydrochloride (cevimeline hydrochloride)

Snippet

ORIG AP for CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)